Literature DB >> 32744576

Sarcopenia Prevalence Using Different Definitions in Older Community-Dwelling Canadians.

S A Purcell1, M MacKenzie, T G Barbosa-Silva, I J Dionne, S Ghosh, O V Olobatuyi, M Siervo, M Ye, C M Prado.   

Abstract

OBJECTIVES: Sarcopenia is a debilitating condition affecting millions of individuals worldwide and is defined with different criteria. The objective of this study was to determine the prevalence of sarcopenia in older Canadians using three internationally accepted criteria.
DESIGN: Observational cohort study. SETTINGS AND PARTICIPANTS: Data from 12,592 subjects [6,314 males (50.1%), 6,278 females (49.9%)] ≥65 years old in the Canadian Longitudinal Study on Aging were included. MEASUREMENTS: Appendicular lean mass (ALM; kg) and appendicular lean mass index (ALM kg/height in m2) were collected from dual X-ray absorptiometry measurements. Physical performance was assessed using the 4-m gait speed test, and muscle strength was measured by hand dynamometry. Sarcopenia was defined according to criteria put forth by the International Working Group on Sarcopenia (IWGS), Foundation for the National Institutes of Health (FNIH) Sarcopenia Project, and revised European Working Group on Sarcopenia in Older People (EWGSOP). Positive and negative percent agreements and Cohen's kappa (κ) described the agreement among sarcopenia definitions.
RESULTS: Among the evaluated criteria, gait speed ≤ 1.0 m/s (IWGS definition of slowness) was the most frequently identified deficit (56.8% males, 57.2% females). The prevalence of sarcopenia ranged from 1.4 to 5.2% in males and 1.6 to 7.2 % in females among the different definitions. Positive percent agreement values among criteria were generally low (range: 1.5 - 55.3%) and corresponded to κ indicating none to minimal agreement (0.01 - 0.23). Negative percent agreement values were ≥ 95%.
CONCLUSION: Sarcopenia prevalence was relatively low in older Canadian adults and current definitions had poor agreement in diagnosing individuals as sarcopenic.

Entities:  

Keywords:  Body composition; muscle function; physical function; physical performance; strength

Mesh:

Year:  2020        PMID: 32744576     DOI: 10.1007/s12603-020-1427-z

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  6 in total

1.  Nutritional Intervention to Prevent the Functional Decline in Community-Dwelling Older Adults: A Systematic Review.

Authors:  Julie Mareschal; Laurence Genton; Tinh-Hai Collet; Christophe Graf
Journal:  Nutrients       Date:  2020-09-15       Impact factor: 5.717

2.  Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines.

Authors:  Dominic Bertschi; Caroline M Kiss; Nadine Beerli; Reto W Kressig
Journal:  Eur J Clin Nutr       Date:  2020-10-15       Impact factor: 4.016

3.  Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy.

Authors:  Michael Zaucha Sørensen; Rasmus Bo Jansen; Tomas Møller Christensen; Per E Holstein; Ole Lander Svendsen
Journal:  J Diabetes Res       Date:  2022-02-17       Impact factor: 4.011

4.  Twelve-year sarcopenia trajectories in older adults: results from a population-based study.

Authors:  Caterina Trevisan; Davide Liborio Vetrano; Riccardo Calvani; Anna Picca; Anna-Karin Welmer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-30       Impact factor: 12.910

5.  Impact of Different Operational Definitions of Sarcopenia on Prevalence in a Population-Based Sample: The Salus in Apulia Study.

Authors:  Luisa Lampignano; Ilaria Bortone; Fabio Castellana; Rossella Donghia; Vito Guerra; Roberta Zupo; Giovanni De Pergola; Marta Di Masi; Gianluigi Giannelli; Madia Lozupone; Francesco Panza; Heiner Boeing; Rodolfo Sardone
Journal:  Int J Environ Res Public Health       Date:  2021-12-09       Impact factor: 3.390

6.  Prevalence of probable sarcopenia in community-dwelling older Greek people.

Authors:  Maria Tsekoura; Evdokia Billis; Charalampos Matzaroglou; Elias Tsepis; John Gliatis
Journal:  J Frailty Sarcopenia Falls       Date:  2021-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.